Yoshiaki Kato

Dr. Yoshiaki Kato

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2022 in HeartRhythm Case Reports
Verified
Journal Article
Open access
YKYoshiaki Kato
Yoshiaki Kato
YNYoshihiro Nozaki
Yoshihiro Nozaki
MTMiho Takahashi-Igari
Miho Takahashi-Igari
MSMasato Sugano
Masato Sugano
NMNaomasa Makita
Naomasa Makita
HHHitoshi Horigome
Hitoshi Horigome

1 August 2019 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
HOHajime Okuwaki
Hajime Okuwaki
YKYoshiaki Kato
Yoshiaki Kato
LLLisheng Lin
Lisheng Lin
YNYoshihiro Nozaki
Yoshihiro Nozaki
MTMiho Takahashi‐Igari
Miho Takahashi‐Igari
HHHitoshi Horigome
Hitoshi Horigome
For applying a genotype-based treatment in neonatal long QT syndrome (LQTS), early detection of the genotype becomes an important issue. We report a case of a neonate with LQTS type 3 that presented with 2:1 atrioventricular block and underwent a mexiletine infusion challenge test, and achieved shortening of the QTc and 1:1 atrioventricular conduction. The mexiletine infusion challenge test was helpful to make an early detection of the genotype of the LQTS and predicted the drug efficacy in a neonatal patient.

23 December 2004 in Hepatology
Verified
Journal Article
Open access
PDF file
MIMotoh Iwasa
Motoh Iwasa
MNMakoto Nakao
Makoto Nakao
YKYoshiaki Kato
Yoshiaki Kato
YKYoshinao Kobayashi
Yoshinao Kobayashi
KTKenji Takagi
Kenji Takagi
YAYukihiko Adaci
Yukihiko Adaci
Click on the article title to read more.

20 November 2023 in Journal of Arrhythmia
Verified
Journal Article
Open access
SOSatoshi Oka
Satoshi Oka
KIKohei Ishibashi
Kohei Ishibashi
YKYoshiaki Kato
Yoshiaki Kato
YTYuji Tominaga
Yuji Tominaga
KKKengo Kusano
Kengo Kusano
Modified procedures of subcutaneous implantable cardioverter defibrillator (S‐ICD) implantation for a child with a small body size are presented. This report demonstrates the feasibility of novel diagonal S‐ICD lead implantation method.

Verified
Journal Article
Open access
PDF file
Isao ShiraishiIsao Shiraishi
Isao Shiraishi
MYMasaaki Yamagishi
Masaaki Yamagishi
THTakaya Hoashi
Takaya Hoashi
YKYoshiaki Kato
Yoshiaki Kato
SIShigemitsu Iwai
Shigemitsu Iwai
KKKenichi Kurosaki
Kenichi Kurosaki
Three-dimensional (3D) printing is an advanced technology for accurately understanding anatomy and supporting the successful surgical management of complex congenital heart disease (CHD). We aimed to evaluate whether our super-flexible 3D heart models could facilitate preoperative decision-making and surgical simulation for complex CHD. The super-flexible heart models were fabricated by stereolithography 3D printing of the internal and external contours of the heart from cardiac computed tomography (CT) data, followed by vacuum casting with a polyurethane material similar in elasticity to a child’s heart. Nineteen pediatric patients with complex CHD were enrolled (median age, 10 months). The primary endpoint was defined as the percentage of patients rated as “essential” on the surgeons’ postoperative 5-point Likert scale. The accuracy of the models was validated by a non-destructive method using industrial CT. The super-flexible heart models allowed detailed anatomical diagnosis and simulated surgery with incisions and sutures. Thirteen patients (68.4%) were classified as “essential” by the primary surgeons after surgery, with a 95% confidence interval of 43.4–87.4%, meeting the primary endpoint. The product error within 90% of the total external and internal surfaces was 0.54 ± 0.21 mm. The super-flexible 3D heart models are accurate, reliable, and useful tools to assist surgeons in decision-making and allow for preoperative simulation in CHD.

20 April 2026 in Journal of Arrhythmia
Verified
Journal Article
Open access
HMHitoshi Mori
Hitoshi Mori
NNNobuhiro Nishii
Nobuhiro Nishii
YKYoshiaki Kato
Yoshiaki Kato
TKTakahiko Kinjo
Takahiko Kinjo
TSTsugutoshi Suzuki
Tsugutoshi Suzuki
NSNaokata Sumitomo
Naokata Sumitomo
Background: Advances in surgical management have improved long‐term survival in patients with congenital heart disease (CHD), leading to a growing population of adults with postoperative arrhythmias. However, contemporary data on catheter ablation practice and outcomes in patients with CHD remain limited. Methods: This multicenter, retrospective registry study included patients who underwent catheter ablation for postoperative CHD‐related arrhythmias between April 2007 and December 2025 at 10 centers. CHD severity was classified as mild, moderate, or severe according to Japanese Circulation Society guidelines. Procedural characteristics, arrhythmia profiles, acute procedural outcomes, and complications were analyzed. Associations between age, disease severity, arrhythmia burden, and procedural success were evaluated using regression analyses. Results: A total of 1 719 patients were included. The number of ablation procedures increased over time across all CHD severity categories. Increasing age was associated with lower disease severity, whereas patients with severe CHD, particularly those after a Fontan repair, underwent ablation at younger ages. Procedural success decreased with increasing CHD severity (complete success: 92.5% in mild, 81.4% in moderate, and 71.4% in severe CHD) and with a greater number of induced arrhythmia types. Overall, procedure‐related complications occurred in 2.3% of patients, with worsening heart failure being the most frequent non‐vascular adverse event. Conclusion: In a large contemporary Japanese cohort, catheter ablation for postoperative CHD‐related arrhythmias was increasingly performed and demonstrated acceptable safety. However, procedural success was lower in patients with more severe CHD and greater arrhythmia complexity, highlighting the need for specialized ablation strategies and careful periprocedural management in this growing population.